Nuclear receptor agonist-driven modification of inflammation and amyloid pathology enhances and sustains cognitive improvements in a mouse model of Alzheimer's disease

Nuclear receptor agonist-driven modification of inflammation and amyloid pathology enhances and sustains cognitive improvements in a mouse model of Alzheimer's disease

The following license files are associated with this item:

This item appears in the following Collection(s)

Attribution 3.0 United States Except where otherwise noted, this item's license is described as Attribution 3.0 United States

Search Repository


My Account

Statistics